CIK: 1248093 - Address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA 94949
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/4/25 20:10
3/3/25
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsKakkis Emil DCADOP,CEOS.dm-4,15442.200-98-32,801M
12/31/24 14:05
12/30/24
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsKakkis Emil DCADOP,CEOS-49542.230-1202,749I
12/11/24 18:44
12/10/24
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsKakkis Emil DCADOP,CEOS-41450.000-802,760I
9/5/24 11:53
9/3/24
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsKakkis Emil DCADOP,CEOS-1,11755.850-20-12,789I
8/7/24 14:48
8/6/24
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsKakkis Emil DCADOP,CEOS-1,00350.170-20-12,809I
2/8/24 15:49
2/7/24
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsKakkis Emil DCADOP,CEOS-1,35045.000-30-12,804D
1/2/24 16:07
12/29/23
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsKakkis Emil DCADOP,CEOS-1,43647.870-30-12,834D
10/23/23 17:14
10/19/23
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsKakkis Emil DCADOP,CEOS.d-1,60433.520-48-22,864D
1/3/23 16:45
12/30/22
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsKakkis Emil DCADOP,CEOS-89245.570-20-12,824D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact